Trials / Unknown
UnknownNCT06179797
Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Augusta University · Academic / Other
- Sex
- All
- Age
- 56 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in patients with age-related cerebral white matter hyperintensities on MRI, in preparation for a subsequent larger efficacy trial.
Detailed description
Objective: The objective of this early phase study is to evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in preparation for a subsequent larger efficacy trial. In addition, we will evaluate the tolerability and adherence to the treatment protocol. Aim: We aim to measure blood biomarkers in response to daily remote ischemic conditioning (RIC) using a dose escalation study design in 40 patients with age-related cerebral white matter hyperintensities on MRI. Hypothesis: We hypothesize that there will be a significant change in the biomarker levels in a dose dependent fashion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | remote ischemic conditioning | suprasystolic BP sequential compression of both arms with blood pressure cuffs for 5 min on/off for 4 cycles. |
Timeline
- Start date
- 2020-08-15
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
- First posted
- 2023-12-22
- Last updated
- 2023-12-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06179797. Inclusion in this directory is not an endorsement.